Accessibility Menu
Futura Medical Plc logo

Futura Medical Plc(OTC) FAMDF

Market Cap$10.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-98%
5 Year-96%
1 Year-89%
1 Month+170%
$0.02
+76.64%
+0.01Today
Futura Medical Plc last closing stock price
MetricPriceDate
Last closeUSD 0.022026-07-23
Futura Medical Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+372.5%USD 0.002026-07-15
1 month+170%USD 0.012026-06-23
3 month-50.26%USD 0.042026-04-21
Year to date+37.45%USD 0.012025-12-31
1 year-88.55%USD 0.172025-07-23
3 year-97.41%USD 0.732023-07-24
5 year-96.22%USD 0.502021-07-20
Since inception-98.23%USD 1.072008-01-29

Futura Medical Plc Financials at a Glance

Market Cap

$10.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£15.62M

Net Income (TTM)

-£7.78M

EPS (TTM)

-$0.04

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

-0.64 (Low)

Price

$0.02

Volume

6,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.20

Estimated Earnings Date

Sep 22, 2026

FAMDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Futura Medical Plc

Futura Medical plc is a pharmaceutical company focused on developing innovative healthcare solutions, particularly in sexual well-being and pain management. The company is known for its flagship product, MED3000, a topical gel designed to treat erectile dysfunction, and has a diverse pipeline of pain relief treatments.

Products and Services
  • MED3000: Topical gel for erectile dysfunction
  • TPR100: Topical diclofenac gel for pain relief
  • CBD100: Topical cannabidiol preparation for discomfort management
Growth Outlook
  • Strong market demand for sexual health products is expected to drive revenue growth
  • Expansion of product pipeline with innovative pain relief solutions
  • Strategic partnerships may enhance market reach and distribution capabilities
Financial Highlights
  • Recent quarterly revenue of 695,392 GBP shows potential for recovery
  • Gross profit margin improved to 72.87% in the latest quarter
  • Cash and cash equivalents stood at 3,401,079 GBP, providing operational flexibility
Futura Medical plc operates in the biotechnology sector, with a focus on addressing unmet medical needs through innovative products. The company has established a solid foundation with its flagship product and is actively working on expanding its portfolio. The recent financial performance indicates a potential turnaround, with improvements in gross profit margins and a healthy cash position. The growth outlook remains positive, driven by increasing demand in the sexual health market and the development of new pain relief products. As the company continues to innovate and expand, it may present an interesting opportunity for investors looking to engage in the healthcare sector.
AI Generated • Jul 25, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Alexander James Hanbury Duggan

Website

www.futuramedical.com

Headquarters

Guildford, SU GU2 7YG, GB

FAMDF Financials

Key Financial Metrics (TTM)

Gross Margin

73.08%

Operating Margin

-333.48%

Net Income Margin

-534.62%

Return on Equity

-310.00%

Return on Capital

-319.62%

Return on Assets

-173.80%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

581.33M

Volume

6.00K

Avg. Volume

15.22K

Financials (TTM)

Gross Profit

£10.44M

Operating Income

-£7.72M

EBITDA

-£7.88M

Operating Cash Flow

-£5.22M

Capital Expenditure

-£1.73M

Free Cash Flow

-£6.95M

Cash & ST Invst.

£3.40M

Total Debt

£0.00

Futura Medical Plc Performance Analysis

Futura Medical Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 0N/A
20232023-12-31GBP 3,854,664N/A
20242024-12-31GBP 17,794,970361.6%
20252025-12-31GBP 2,236,012-87.4%
Futura Medical Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30400.9%
Q42024-12-31-1.1%
Q22025-06-30-85.5%
Q42025-12-31-30.5%
Futura Medical Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.03-0.4%
20232023-12-31GBP -0.039.2%
20242024-12-31GBP 0.01N/A
20252025-12-31GBP -0.04N/A
Futura Medical Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30120.3%
Q42024-12-31-75.0%
Q22025-06-30-2812.5%
Q42025-12-3180.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£695.39K

-50.2%

Gross Profit

£506.75K

-41.4%

Gross Margin

72.87%

N/A

Market Cap

$10.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$784.79K

N/A

Employees

14

N/A

Net Income

-£2.48M

+47.7%

EBITDA

-£2.58M

+47.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£3.40M

-55.9%

Total Debt

£0.00

N/A

Accounts Receivable

£1.07M

-6.8%

Inventory

£259.96

-23.3%

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-1.74%

N/A

Return on Invested Capital

-1.86%

N/A

Free Cash Flow

-£2.64M

-671.6%

Operating Cash Flow

-£2.64M

-327.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCLOFPharmaCielo Ltd.
$0.05+15.91%
KNBIFKane Biotech Inc.
$0.02+11.38%
BVAXFBioVaxys Technology Corp.
$0.11+0.00%
ENSCEnsysce Biosciences, Inc.
$0.25+0.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About FAMDF

What is the current price of Futura Medical Plc?

Futura Medical Plc is trading at $0.02 per share.

What is the 52-week range for Futura Medical Plc?

Over the past 52 weeks, Futura Medical Plc has traded between $0.00 and $0.20.

How much debt does Futura Medical Plc have?

As of the most recent reporting period, Futura Medical Plc reported total debt of £0.00.

How much cash does Futura Medical Plc have on hand?

Futura Medical Plc reported £4.58M in cash and cash equivalents in its most recent financial results.

What is Futura Medical Plc’s dividend yield?

Futura Medical Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services